{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:23:49Z","timestamp":1748593429045,"version":"3.40.5"},"reference-count":55,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIAID Collaborative Influenza Vaccine Innovation Centers","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Post vaccine immunity following COVID-19 mRNA vaccination may be driven by extrinsic, or controllable and intrinsic, or inherent health factors. Thus, we investigated the effects of extrinsic and intrinsic on the peak antibody response following COVID-19 primary vaccination and on the trajectory of peak antibody magnitude and durability over time. Participants in a longitudinal cohort attended visits every 3 months for up to 2 years following enrollment. At baseline, participants provided information on their demographics, recreational behaviors, and comorbid health conditions which guided our model selection process. Blood samples were collected for serum processing and spike antibody testing at each visit. Cross-sectional and longitudinal models (linear-mixed effects models) were generated to assess the relationship between selected intrinsic and extrinsic health factors on peak antibody following vaccination and to determine the influence of these predictors on antibody over time. Following cross-sectional analysis, we observed higher peak antibody titers after primary vaccination in females, those who reported recreational drug use, younger age, and prior COVID-19 history. Following booster vaccination, females and Hispanics had higher peak titers after the 3<jats:sup>rd<\/jats:sup> and 4<jats:sup>th<\/jats:sup> doses, respectively. Longitudinal models demonstrated that Moderna mRNA-1273 recipients, females, and those previously vaccinated had increased peak titers over time. Moreover, drug users and half-dose Moderna mRNA-1273 recipients had higher peak antibody titers over time following the first booster, while no predictive factors significantly affected post-second booster antibody responses. Overall, both intrinsic and extrinsic health factors play a significant role in shaping humoral immunogenicity after initial vaccination and the first booster. The absence of predictive factors for second booster immunogenicity suggests a more robust and consistent immune response after the second booster vaccine administration.<\/jats:p>","DOI":"10.1371\/journal.pone.0292566","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T18:24:18Z","timestamp":1712082258000},"page":"e0292566","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Determinants of health as predictors for differential antibody responses following SARS-CoV-2 primary and booster vaccination in an at-risk, longitudinal cohort"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0408-697X","authenticated-orcid":true,"given":"Felipe","family":"Echeverri Tribin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeska","family":"Testamarck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominika","family":"Bielak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temima","family":"Yellin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hoffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Pallikkuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Savita","family":"Pahwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"pone.0292566.ref001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-med-042921-020956","article-title":"COVID-19: Challenges of Viral Variants","volume":"74","author":"JL Jacobs","year":"2023","journal-title":"Annu Rev Med"},{"issue":"26","key":"pone.0292566.ref002","doi-asserted-by":"crossref","first-page":"6243","DOI":"10.1016\/j.cell.2021.11.033","article-title":"SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis","volume":"184","author":"D Wendisch","year":"2021","journal-title":"Cell"},{"issue":"1","key":"pone.0292566.ref003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-0042-1759779","article-title":"COVID-19 Vaccines-All You Want to Know","volume":"44","author":"AA Shishido","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"pone.0292566.ref004","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/ijmm.2020.4794","article-title":"Approaches towards fighting the COVID\u201119 pandemic (Review)","volume":"47","author":"SC Tsai","year":"2021","journal-title":"Int J Mol Med"},{"key":"pone.0292566.ref005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.971277","article-title":"Predictors for reactogenicity and humoral immunity to SARS-CoV-2 following infection and mRNA vaccination: A regularized, mixed-effects modelling approach","volume":"14","author":"EC Williams","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"pone.0292566.ref006","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamainternmed.2021.7257","article-title":"Emergency Use Authorizations of COVID-19-Related Medical Products","volume":"182","author":"I Moshkovits","year":"2022","journal-title":"JAMA Intern Med"},{"key":"pone.0292566.ref007","doi-asserted-by":"crossref","first-page":"e934625","DOI":"10.12659\/MSM.934625","article-title":"Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy","volume":"27","author":"DV Parums","year":"2021","journal-title":"Med Sci Monit"},{"issue":"6","key":"pone.0292566.ref008","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s11596-021-2395-1","article-title":"A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics","volume":"41","author":"L Forchette","year":"2021","journal-title":"Curr Med Sci"},{"issue":"7","key":"pone.0292566.ref009","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1002\/jmv.26982","article-title":"Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection","volume":"93","author":"A Callegaro","year":"2021","journal-title":"J Med Virol"},{"issue":"2","key":"pone.0292566.ref010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/infdis\/jiaa618","article-title":"Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection","volume":"223","author":"KHD Crawford","year":"2021","journal-title":"J Infect Dis"},{"issue":"13","key":"pone.0292566.ref011","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection","volume":"386","author":"V Hall","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0292566.ref012","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155889","article-title":"SARS-CoV-2 BNT162b2 vaccine-induced humoral response and reactogenicity in individuals with prior COVID-19 disease","volume":"7","author":"SG Kelsen","year":"2022","journal-title":"JCI Insight"},{"issue":"8","key":"pone.0292566.ref013","doi-asserted-by":"crossref","first-page":"109570","DOI":"10.1016\/j.celrep.2021.109570","article-title":"Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals","volume":"36","author":"D Lozano-Ojalvo","year":"2021","journal-title":"Cell Rep"},{"issue":"12","key":"pone.0292566.ref014","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1002\/jmv.27263","article-title":"Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection, and change to single-dose vaccination","volume":"93","author":"R Mungmunpuntipantip","year":"2021","journal-title":"J Med Virol"},{"issue":"4","key":"pone.0292566.ref015","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001291","article-title":"Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan","volume":"70","author":"M Nagura-Ikeda","year":"2021","journal-title":"J Med Microbiol"},{"key":"pone.0292566.ref016","doi-asserted-by":"crossref","first-page":"103656","DOI":"10.1016\/j.ebiom.2021.103656","article-title":"Influence of past infection with SARS-CoV-2 on the response to the BNT162b2 mRNA vaccine in health care workers: Kinetics and durability of the humoral immune response","volume":"73","author":"J Onta\u00f1\u00f3n","year":"2021","journal-title":"EBioMedicine"},{"issue":"10","key":"pone.0292566.ref017","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.cmi.2022.05.009","article-title":"Heterologous gam-COVID-vac (sputnik V)\/mRNA-1273 (moderna) vaccination induces a stronger humoral response than homologous sputnik V in a real-world data analysis","volume":"28","author":"MJ Pereson","year":"2022","journal-title":"Clinical Microbiology and Infection"},{"issue":"6","key":"pone.0292566.ref018","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.it.2020.04.001","article-title":"Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?","volume":"41","author":"JS Tsang","year":"2020","journal-title":"Trends Immunol"},{"issue":"12","key":"pone.0292566.ref019","doi-asserted-by":"crossref","first-page":"e82779","DOI":"10.1371\/journal.pone.0082779","article-title":"Is Obesity a Risk Factor for Vaccine Non-Responsiveness?","volume":"8","author":"KM Young","year":"2013","journal-title":"PLOS ONE"},{"key":"pone.0292566.ref020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940357","article-title":"Immunogenicity of COVID-19 vaccines in patients with diabetes mellitus: A systematic review","volume":"13","author":"AB Boroumand","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"pone.0292566.ref021","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/cid\/cit209","article-title":"Heterologous (\u201cNonspecific\u201d) and Sex-Differential Effects of Vaccines: Epidemiology, Clinical Trials, and Emerging Immunologic Mechanisms","volume":"57","author":"Network ftO","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"15","key":"pone.0292566.ref022","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2014.01.057","article-title":"The link between genetic variation and variability in vaccine responses: Systematic review and meta-analyses","volume":"32","author":"B Posteraro","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"pone.0292566.ref023","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03324904","article-title":"Immunosenescence and vaccine failure in the elderly","volume":"21","author":"B Grubeck-Loebenstein","year":"2009","journal-title":"Aging Clinical and Experimental Research"},{"issue":"4","key":"pone.0292566.ref024","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.7.4.467","article-title":"Age-related decline in immunity: implications for vaccine responsiveness","volume":"7","author":"R Kumar","year":"2008","journal-title":"Expert Review of Vaccines"},{"issue":"3","key":"pone.0292566.ref025","doi-asserted-by":"crossref","first-page":"e0017922","DOI":"10.1128\/msphere.00179-22","article-title":"PARIS and SPARTA: Finding the Achilles\u2019 Heel of SARS-CoV-2","volume":"7","author":"V Simon","year":"2022","journal-title":"mSphere"},{"issue":"2","key":"pone.0292566.ref026","doi-asserted-by":"crossref","first-page":"100796","DOI":"10.1016\/j.ajogmf.2022.100796","article-title":"Longitudinal antibody response kinetics following SARS-CoV-2 messenger RNA vaccination in pregnant and nonpregnant persons","volume":"5","author":"M Prabhu","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"12","key":"pone.0292566.ref027","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.3390\/vaccines9121508","article-title":"Assessment of Post-Vaccination Antibody Response Eight Months after the Administration of BNT1622b2 Vaccine to Healthcare Workers with Particular Emphasis on the Impact of Previous COVID-19 Infection","volume":"9","author":"B Wolszczak-Biedrzycka","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"pone.0292566.ref028","unstructured":"HANC. Cross-Network PBMC Processing Standard Operating Procedure. 2018. p. 1\u201345."},{"issue":"1","key":"pone.0292566.ref029","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1002\/cpmc.100","article-title":"SARS-CoV-2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup","volume":"57","author":"D Stadlbauer","year":"2020","journal-title":"Curr Protoc Microbiol"},{"issue":"7","key":"pone.0292566.ref030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41591-020-0913-5","article-title":"A serological assay to detect SARS-CoV-2 seroconversion in humans","volume":"26","author":"F Amanat","year":"2020","journal-title":"Nat Med"},{"issue":"1","key":"pone.0292566.ref031","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/imr.13089","article-title":"Immunological memory to SARS-CoV-2 infection and COVID-19 vaccines","volume":"310","author":"A Sette","year":"2022","journal-title":"Immunol Rev"},{"issue":"10","key":"pone.0292566.ref032","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1473-3099(07)70237-2","article-title":"Vaccine immunogenicity in injecting drug users: a systematic review","volume":"7","author":"S Baral","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pone.0292566.ref033","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1128\/CMR.16.2.209-219.2003","article-title":"Microbial infections, immunomodulation, and drugs of abuse","volume":"16","author":"H Friedman","year":"2003","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"pone.0292566.ref034","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1574-695X.2006.00097.x","article-title":"Addictive drugs and their relationship with infectious deseases","volume":"47","author":"H Friedman","year":"2006","journal-title":"FEMS Immunology & Medical Microbiology"},{"key":"pone.0292566.ref035","doi-asserted-by":"crossref","first-page":"108696","DOI":"10.1016\/j.intimp.2022.108696","article-title":"Dynamics and correlations in multiplex immune profiling reveal persistent immune inflammation in male drug users after withdrawal","volume":"107","author":"G-F Re","year":"2022","journal-title":"International Immunopharmacology"},{"issue":"12","key":"pone.0292566.ref036","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-021-01162-5","article-title":"T Cell Immunometabolism and Redox Signaling in Hypertension","volume":"23","author":"DL Mattson","year":"2021","journal-title":"Curr Hypertens Rep"},{"issue":"12","key":"pone.0292566.ref037","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/ars.2020.8042","article-title":"The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension","volume":"34","author":"CM Moshfegh","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"10","key":"pone.0292566.ref038","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/HJH.0000000000002456","article-title":"Adaptive immune disorders in hypertension and heart failure: focusing on T-cell subset activation and clinical implications","volume":"38","author":"A Rai","year":"2020","journal-title":"J Hypertens"},{"issue":"30","key":"pone.0292566.ref039","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1016\/j.vaccine.2022.05.059","article-title":"Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2","volume":"40","author":"G Soegiarto","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"pone.0292566.ref040","doi-asserted-by":"crossref","first-page":"e3465","DOI":"10.1002\/dmrr.3465","article-title":"Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID-19 mRNA vaccine","volume":"38","author":"M Watanabe","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"pone.0292566.ref041","doi-asserted-by":"crossref","first-page":"100928","DOI":"10.1016\/j.eclinm.2021.100928","article-title":"Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine","volume":"36","author":"R Pellini","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"14","key":"pone.0292566.ref042","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1056\/NEJMc2101667","article-title":"Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine","volume":"384","author":"F Krammer","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"pone.0292566.ref043","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.571416","article-title":"Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?","volume":"11","author":"V Bajaj","year":"2021","journal-title":"Frontiers in Physiology"},{"issue":"5","key":"pone.0292566.ref044","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.jaci.2020.03.017","article-title":"Influence of immune aging on vaccine responses","volume":"145","author":"CE Gustafson","year":"2020","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"1","key":"pone.0292566.ref045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1600-065X.1997.tb01027.x","article-title":"Age-related changes in antibody repertoire: contribution from T cells","volume":"160","author":"H Song","year":"1997","journal-title":"Immunological Reviews"},{"issue":"16","key":"pone.0292566.ref046","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0264-410X(99)00497-1","article-title":"Changes in the B-cell repertoire with age","volume":"18","author":"ME Weksler","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"pone.0292566.ref047","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1172\/JCI64096","article-title":"Causes, consequences, and reversal of immune system aging","volume":"123","author":"E Montecino-Rodriguez","year":"2013","journal-title":"J Clin Invest"},{"key":"pone.0292566.ref048","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cophys.2018.03.010","article-title":"The evolution of greater humoral immunity in females than males: implications for vaccine efficacy","volume":"6","author":"AL Fink","year":"2018","journal-title":"Curr Opin Physiol"},{"issue":"10","key":"pone.0292566.ref049","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","article-title":"Sex differences in immune responses","volume":"16","author":"SL Klein","year":"2016","journal-title":"Nature Reviews Immunology"},{"key":"pone.0292566.ref050","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3389\/fimmu.2019.01076","article-title":"Editorial: Sex Hormones and Gender Differences in Immune Responses","volume":"10","author":"E Ortona","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"pone.0292566.ref051","doi-asserted-by":"crossref","first-page":"677","DOI":"10.5858\/arpa.2021-0607-SA","article-title":"Comparison of Symptoms and Antibody Response Following Administration of Moderna or Pfizer SARS-CoV-2 Vaccines","volume":"146","author":"MT Kelliher","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"pone.0292566.ref052","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.850987","article-title":"Trajectory of IgG to SARS-CoV-2 After Vaccination With BNT162b2 or mRNA-1273 in an Employee Cohort and Comparison With Natural Infection","volume":"13","author":"B Keshavarz","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"pone.0292566.ref053","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41541-023-00638-6","article-title":"SARS-CoV-2 spike-ferritin-nanoparticle adjuvanted with ALFQ induces long-lived plasma cells and cross-neutralizing antibodies","volume":"8","author":"S Shrivastava","year":"2023","journal-title":"npj Vaccines"},{"key":"pone.0292566.ref054","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.7717.1","article-title":"The germinal center antibody response in health and disease","volume":"5","author":"AL DeFranco","year":"2016","journal-title":"F1000Res"},{"issue":"4","key":"pone.0292566.ref055","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2014.10.004","article-title":"T follicular helper cell differentiation, function, and roles in disease","volume":"41","author":"S. Crotty","year":"2014","journal-title":"Immunity"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292566","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T18:24:56Z","timestamp":1712082296000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0292566"}},"subtitle":[],"editor":[{"given":"Gurudeeban","family":"Selvaraj","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0292566","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,4,2]]}}}